The findings of Maynard et al. showed that mononuclear cells of peripheral blood had lower APE1 activity and reduced DNA repair efficiency in AD patients and that these biochemical activities are reliable biomarkers for AD [79]. Here, APEX1 is linked to Alzheimer disease.